This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 1.89% to $6.22 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 2.15% to 22,078.05 and Dow Jones Industrial Average  falling 0.84% to 45,752.26.
This was the stock's seventh consecutive day of losses.
Novavax Inc. closed 46.15% below its 52-week high of $11.55, which the company achieved on January 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) rose 0.28% to $203.07, Pfizer Inc. (PFE) fell 1.93% to $24.40, and Merck &amp; Co. Inc. (MRK) fell 0.08% to $94.97.
Trading volume (3.9 M) remained 632,522 below its 50-day average volume of 4.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-20-25 1728ET

NVAX

<p>Novavax Inc.'s stock fell 1.89% to $6.22 on Thursday, marking its seventh consecutive day of losses. The stock is 46.15% below its 52-week high. In comparison, Johnson & Johnson rose 0.28%, while Pfizer and Merck fell 1.93% and 0.08%, respectively. Trading volume was below the 50-day average. The NASDAQ and Dow Jones also experienced declines.</p>

- Novavax Inc. (NVAX) shares fell 1.89% to $6.22 amid a broader market decline, with the NASDAQ Composite down 2.15%.  
- This marks the seventh consecutive day of losses for Novavax, which is now 46.15% below its 52-week high of $11.55 reached on January 7th.  
- Trading volume was 3.9 million, falling short of the 50-day average of 4.5 million, while competitors showed mixed results.  

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors